作者: Norman Muirhead , David N. Churchill , Marc Goldstein , Steven P. Nadler , Gerald Posen
DOI: 10.1159/000168464
关键词:
摘要: While recombinant human erythropoietin (rHuEPO) is an effective therapy for anemia in renal failure, most published studies concern benefits relatively healthy hemodialysis patients. The present st